The treatment of iron deficiency without anaemia (in otherwise healthy persons)

Iron deficiency is the most widespread and frequent nutritional disorder in the world. It affects a high proportion of children and women in developing countries and is also significantly prevalent in the industrialised world, with a clear predominance in adolescents and menstruating females. Iron...

Full description

Bibliographic Details
Main Author: German E. Clénin
Format: Article
Language:English
Published: SMW supporting association (Trägerverein Swiss Medical Weekly SMW) 2017-06-01
Series:Swiss Medical Weekly
Subjects:
Online Access:https://www.smw.ch/index.php/smw/article/view/2310
_version_ 1811288485348245504
author German E. Clénin
author_facet German E. Clénin
author_sort German E. Clénin
collection DOAJ
description Iron deficiency is the most widespread and frequent nutritional disorder in the world. It affects a high proportion of children and women in developing countries and is also significantly prevalent in the industrialised world, with a clear predominance in adolescents and menstruating females. Iron is essential for optimal cognitive function and physical performance, not only as a binding site of oxygen but also as a critical constituent of many enzymes. Therefore iron deficiency at all levels – nonanaemic iron deficiency, iron deficiency with microcytosis or hypochromia and iron deficiency anaemia – should be treated. In the presence of normal stores, however, preventative iron administration is inefficient, has side effects and seems to be harmful. In symptomatic patients with fatigue or in a population at risk for iron deficiency (adolescence, heavy or prolonged menstruation, high performance sport, vegetarian or vegan diet, eating disorder, underweight), a baseline set of blood tests including haemoglobin concentration, haematocrit, mean cellular volume, mean cellular haemoglobin, percentage of hypochromic erythrocytes and serum ferritin levels are important to monitor iron deficiency. To avoid false negative results (high ferritin levels in spite of iron deficiency), an acute phase reaction should be excluded by history and measurement of C-reactive protein. An algorithm leads through this diagnostic process and the decision making for a possible treatment. For healthy males and females aged >15 years, a ferritin cut-off of 30 µg/l is appropriate. For children from 6–12 years and younger adolescents from 12–15 years, cut-offs of 15 and 20 µg/l, respectively, are recommended. As a first step in treatment, counselling and oral iron therapy are usually combined. Integrating haem and free iron regularly into the diet, looking for enhancers and avoiding inhibitors of iron uptake is beneficial. In order to prevent reduced compliance, mainly as a result of gastrointestinal side effects of oral treatment, the use of preparations with reasonable but not excessive elemental iron content (28–50 mg) seems appropriate. Only in exceptional cases will an intravenous injection be necessary (e.g., concomitant disease needing urgent treatment, repeated failure of first-step therapy).To measure the success of treatment, the basic blood tests should be repeated after 8 to 10 weeks. Patients with repeatedly low ferritin will benefit from intermittent oral substitution to preserve iron stores and from long term follow-up, with the basic blood tests repeated every 6 or 12 months to monitor iron stores. Long-term daily oral or intravenous iron supplementation in the presence of normal or even high ferritin values is, however, not recommended and is potentially harmful.
first_indexed 2024-04-13T03:37:54Z
format Article
id doaj.art-342696edbd1f4f56b32dfc10b0cb41fc
institution Directory Open Access Journal
issn 1424-3997
language English
last_indexed 2024-04-13T03:37:54Z
publishDate 2017-06-01
publisher SMW supporting association (Trägerverein Swiss Medical Weekly SMW)
record_format Article
series Swiss Medical Weekly
spelling doaj.art-342696edbd1f4f56b32dfc10b0cb41fc2022-12-22T03:04:16ZengSMW supporting association (Trägerverein Swiss Medical Weekly SMW)Swiss Medical Weekly1424-39972017-06-01147232410.4414/smw.2017.14434The treatment of iron deficiency without anaemia (in otherwise healthy persons)German E. Clénin Iron deficiency is the most widespread and frequent nutritional disorder in the world. It affects a high proportion of children and women in developing countries and is also significantly prevalent in the industrialised world, with a clear predominance in adolescents and menstruating females. Iron is essential for optimal cognitive function and physical performance, not only as a binding site of oxygen but also as a critical constituent of many enzymes. Therefore iron deficiency at all levels – nonanaemic iron deficiency, iron deficiency with microcytosis or hypochromia and iron deficiency anaemia – should be treated. In the presence of normal stores, however, preventative iron administration is inefficient, has side effects and seems to be harmful. In symptomatic patients with fatigue or in a population at risk for iron deficiency (adolescence, heavy or prolonged menstruation, high performance sport, vegetarian or vegan diet, eating disorder, underweight), a baseline set of blood tests including haemoglobin concentration, haematocrit, mean cellular volume, mean cellular haemoglobin, percentage of hypochromic erythrocytes and serum ferritin levels are important to monitor iron deficiency. To avoid false negative results (high ferritin levels in spite of iron deficiency), an acute phase reaction should be excluded by history and measurement of C-reactive protein. An algorithm leads through this diagnostic process and the decision making for a possible treatment. For healthy males and females aged >15 years, a ferritin cut-off of 30 µg/l is appropriate. For children from 6–12 years and younger adolescents from 12–15 years, cut-offs of 15 and 20 µg/l, respectively, are recommended. As a first step in treatment, counselling and oral iron therapy are usually combined. Integrating haem and free iron regularly into the diet, looking for enhancers and avoiding inhibitors of iron uptake is beneficial. In order to prevent reduced compliance, mainly as a result of gastrointestinal side effects of oral treatment, the use of preparations with reasonable but not excessive elemental iron content (28–50 mg) seems appropriate. Only in exceptional cases will an intravenous injection be necessary (e.g., concomitant disease needing urgent treatment, repeated failure of first-step therapy).To measure the success of treatment, the basic blood tests should be repeated after 8 to 10 weeks. Patients with repeatedly low ferritin will benefit from intermittent oral substitution to preserve iron stores and from long term follow-up, with the basic blood tests repeated every 6 or 12 months to monitor iron stores. Long-term daily oral or intravenous iron supplementation in the presence of normal or even high ferritin values is, however, not recommended and is potentially harmful. https://www.smw.ch/index.php/smw/article/view/2310iron and nutritioniron deficiencyiron therapyNAIDovertreatmenttreatment with iron
spellingShingle German E. Clénin
The treatment of iron deficiency without anaemia (in otherwise healthy persons)
Swiss Medical Weekly
iron and nutrition
iron deficiency
iron therapy
NAID
overtreatment
treatment with iron
title The treatment of iron deficiency without anaemia (in otherwise healthy persons)
title_full The treatment of iron deficiency without anaemia (in otherwise healthy persons)
title_fullStr The treatment of iron deficiency without anaemia (in otherwise healthy persons)
title_full_unstemmed The treatment of iron deficiency without anaemia (in otherwise healthy persons)
title_short The treatment of iron deficiency without anaemia (in otherwise healthy persons)
title_sort treatment of iron deficiency without anaemia in otherwise healthy persons
topic iron and nutrition
iron deficiency
iron therapy
NAID
overtreatment
treatment with iron
url https://www.smw.ch/index.php/smw/article/view/2310
work_keys_str_mv AT germaneclenin thetreatmentofirondeficiencywithoutanaemiainotherwisehealthypersons
AT germaneclenin treatmentofirondeficiencywithoutanaemiainotherwisehealthypersons